Starbucks

The company provides a high-level disclosure of its key purchased proteins. In its annual report, it highlights that it purchases significant amounts of dairy and states that meats and eggs are also significant to its operations. In its 2018 EB report, the company breaks down the environmental footprint of its animal proteins which include eggs, pork, beef, and chicken. The company does not mention seafood, and this does not appear on its current menu in the US.

According to its 2022 Global Environmental and Social Impact Report, the company set a goal to eliminate the routine use of MIAs in poultry served in its company-operated US stores by 2020. This is in line with the WHO recommendations 1,2, and 3 for Medically Important Antimicrobials but does not extend beyond routine use to align with recommendations 4a or 4b. The company achieved its goal for poultry in 2018 but has made no further commitments or policies to reduce the use of any category of antibiotics in its other animal protein supply chains. In its 2023 Global Impact Report, Starbucks reported that 99.9% of poultry served in its US company-operated stores was raised without routine use of MIAs. In its Animal Welfare-Friendly Practices, the company established a buying preference in North America for dairy, meat, and eggs that are produced using industry best practices. As part of this preference, it states that it currently supports eliminating the routine uses of MIAs for growth promotion and disease prevention. The company has not introduced any policies to consolidate this.

The company has a policy to eliminate the routine use of MIAs in poultry served in its company-operated US stores. This represents about 25% of its total stores. This policy does not extend to its US franchised stores or any other location. The company does not have any other antibiotic use policies.

The company disclosed that no MIAs have been routinely used in its poultry purchased for US company-operated stores since 2018. The company does not publicly report that it collects information on the volume of antibiotics used in its supply chain for any of its other key proteins or locations.

The company does not disclose evidence that antibiotic use in its poultry for US stores is audited by a third party.

In its 2023 Global Impact Report, the company discloses that it continues to serve poultry in US company-operated stores that has been raised without the routine use of MIAs. Outside of this statement, the company does not provide any evidence that it is tracking levels of non-compliance. It also does not disclose how it manages non-compliance related to this policy. As part of its ‘Animal Welfare-Friendly Practises’, the company states that if any issues occur in its supply chain, its approach is to work with the suppliers to correct the issues, but that it will also consider pausing transactions until a resolution is found. The company has not stated if similar actions would be taken for non-compliance with its antibiotic policy for poultry supplied to its US company-operated stores.

The company has disclosed that it achieved its target to eliminate the use of MIAs in its poultry served in its company-operated US stores in 2018. No reduction targets for any of its other key proteins have since been introduced.

The company achieved its target to eliminate the use of MIAs in the poultry served in its company-operated US stores. It has not introduced a reduction target for any of its company-operated stores outside of the US or for any of its franchised stores globally.

The company achieved its antibiotic reduction target for poultry in its US company-operated stores in 2018. The company has no other targets related to antibiotic use in its key animal proteins.

Starbucks has confirmed that it will participate in a dialogue with FAIRR and a group of investors for the next phase of the engagement.